sium (Ke) at the three stages of the course of liver cirrhosis. The action of K-sparing diuretics (spironolactone, triamterene, amiloride) on these parameters is analysed. Although the introduction of these diuretics in our therapeutic armamentarium has resulted in a major advance, i.e. the quasi-total elimination of iatrogenic hypokalaemia and hypokalaemia-induced portacaval encephalopathy in the cirrhotic, the limits of their action on K metabolism are underlined: they may moderately enhance urinary K output; following cessation of their administration, a 'rebound' in urinary K output may be noted. Finally, Ke may still continue to decrease during their administration, indicating an aggravation of the underlying disease. It was also found that a rise in serum K and/or Ke during amiloride administration did not prevent the elevation of plasma renin activity usually induced by volume and/or Na depletion.
THE retention of salt and water in the cirrhotic patient requires the administration of diuretics. Following the initial publication by Read et al. (1959) of studies of cirrhotic patients treated with chlorothiazide, it became apparent that severe accidentsespecially portacaval encephalopathy related to diuretic-induced hypokalaemia-were quite common. An increased production of ammonium by the kidney was shown to follow diuretic-induced (or spontaneous) hypokalemia (Gabuzda and Hall, 1966) . Therefore, a better comprehension of K metabolism in patients with liver cirrhosis is of major therapeutic interest. We shall first review the anomalies of K metabolism at the three stages of liver cirrhosis which we have identified (Vesin, 1972a Traverso et al. (1966) . ('hyperaldosteronic' oedema) . Ks is either normal or at the lower limit of normality (Traverso et al., 1966) . In some cases, especially those complicated by diarrhoea, a major cause of K depletion, marked hypokalaemia (< 3 Traverso et al. (1966 ), Vesin et al. (1972 . Only seven of the thirty patients investigated by our group (Traverso et al., 1966; Vesin et al., 1972) had a normal Ke, in the remaining twenty-three, Ke was markedly decreased, sometimes below 500% of the theoretically normal value.
Casey et al. (1965) , Traverso et al. (1966) and Vesin et al. (1972) all stressed the prognostic value of a strong reduction in Ke, especially when developing at repeated determinations. The mechanism of Ke decrease is complex. Vesin (1972a) analysed the responsible factors, namely: reduced K intake due to lack of appetite; destruction of the cellular mass; diarrhoea; diuretics; alkalosis; although hypersecretion of aldosterone is common in these patients, Ku, as mentioned above, is not markedly increased and may even be lowered as noted by Vesin and Traverso (1975 (Vesin, 1972a) . In the patients given amiloride, the excretion of K seemed to be directly related to the urinary output of Na, an indirect finding in favour of the role of an increased aldosterone secretion (Vesin et al., 1969) . The increased aldosterone secretion enhances distal tubular Na resorption and the transtubular electric gradient is increased, resulting in a greater excretion of K into the tubular lumen. The usual increase in Ks may also be a factor of urinary K excretion.
Secondly, the 'rebound' noted by Surveyor and Saunders (1968) during the administration of amiloride may sometimes be observed only after cessation of diuretic therapy, as exemplified on Fig. 1 , showing the Ku changes seen in a patient given spironolactone; the 'rebound' may be of great magnitude, e.g. up to 400 mEq/day in one of the patients treated with spironolactone (Vesin et al., 1972) ; the action of aldosterone hypersecretion may also represent a reasonable explanation for the increased Ku. Thirdly, the eventual changes in Ke were also investigated in patients with liver cirrhosis treated by a K-sparing diuretic. Amiloride (30 mg/day) was given to ten patients for a period of 10 days. Ke was determined before, and on the last day of the administration of amiloride and the following (Vesin et al., 1972) . Similar observations were made by Levy et al. (1970) in cirrhotics treated with spironolactone.
How can one explain the maintenance or even the decrease of Ke instead of the increase one would expect with K-sparing diuretics? The two following mechanisms are proposed:
(1) In some patients, the increase in Ku suffices to account for a moderately negative K balance, inasmuch as K intake is more or less reduced.
(2) Extra-urinary sources of K loss may also exist, with special reference to diarrhoea.
Furthermore, the K-sparing diuretics do not suppress a major anomaly of K metabolism in these patients: the inability of the cells to retain or bind K as shown by Nagant de Deuxchaisnes et al. (1961) in cirrhotic patients given a large K load. The inability of the cells to bind K may also account for the 'rebound' in urinary K excretion reported above, following cessation of K-sparing diuretic administration. As the loss of large amounts of K in the urine does not result in a dramatic decrease in serum K, this cation is likely to have been retained in a loose form in the cells under the action of the K-sparing diuretics. The cessation of this action with the termination of diuretic administration is accompanied by release of the retained K which is eliminated in the urine. For this reason, supplementation of cirrhotic patients with K chloride during the administration of K-sparing diuretics, advocated by Levy et al. (1970) , can only result, in the opinion of Vesin et al. (1972) , in a transient Ke increase at the best, and may even prove dangerous if severe functional renal failure develops during diuretic therapy. It is only in those patients in whom there is a marked improvement of the general condition and liver function that a significant and lasting Ke increase can be expected. It is also worth mentioning that in four patients treated with prednisone with loss of oedema and general improvement, a mean Ke increase of 12 % was noted by Traverso et al. (1966) .
Finally, the effect of an increased Ke and/or Ks following amiloride administration on plasma renin activity (PRA) was investigated. It has been reported repeatedly that a potassium load results in a decrease in PRA. Nevertheless, it was observed, in this investigation, that the retention of K and/or the increase in Ks did not prevent the increase in PRA usually observed after volume and/or Na depletion (Vesin et al., 1972) . These findings have been confirmed by Dluhy, Cain and Williams (1974) in normal subjects in whom the administration of diuretics and the ensuing plasma and/or Na depletion resulted in an increased PRA, despite the concomitant administration of a K load.
